Yasushi Kasahara
Niigata, 9518510, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
NKG2D-based CAR-T cells for synovial sarcoma: A preclinical proof-of-concept study.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 02, 2026
A novel method for generating chimeric antigen receptor-transduced primary human natural killer cells by the use of multiple cytokines and anti-CD2 and anti-NKp46 stimulatory antibodies.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 02, 2025
Chimeric PD‑1 receptor redirects primary T cells against childhood solid tumors but not to PD‑1 ligand‑positive CD80‑coexpressing cells.
Journal: Molecular medicine reports
Published: February 19, 2025
NKp44-based chimeric antigen receptor effectively redirects primary T cells against synovial sarcoma.
Journal: Translational oncology
Published: April 08, 2022
Effectiveness of 4-1BB-costimulated HER2-targeted chimeric antigen receptor T cell therapy for synovial sarcoma.
Journal: Translational oncology
Published: August 02, 2021
Fatal Progressive Meningoencephalitis Diagnosed in Two Members of a Family With X-Linked Agammaglobulinemia.
Journal: Frontiers in pediatrics
Published: June 05, 2020
Development and characterisation of NKp44-based chimeric antigen receptors that confer T cells with NK cell-like specificity.
Journal: Clinical & translational immunology
Published: November 27, 2019
Alveolar rhabdomyosarcoma after treatment of osteosarcoma.
Journal: Pediatrics international : official journal of the Japan Pediatric Society
Published: December 26, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026